Geronikaki A A, Pitta E P, Liaras K S
School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece.
Curr Med Chem. 2013;20(36):4460-80. doi: 10.2174/09298673113209990143.
Antioxidants are of great interest because of their involvement in important biological and industrial processes. According to Halliwell antioxidants are substances that at low concentration significantly delay or prevent oxidation. Chemically, oxidation is a process in which a loss of electrons occurs. Oxidants play a significant role in the pathogenesis of a number of disorders leading to oxidative stress. Oxidative stress may be defined as an imbalance between cellular production of reactive oxygen species and antioxidant defense mechanisms. ROS (e.g., superoxide radical, peroxynitryl, hydroxyl radical and hydrogen peroxide) are constantly produced as a result of metabolic reactions in living systems. Oxidative damage caused by ROS is responsible for many degenerative diseases such as cancer, atherosclerosis, diabetes, cirrhosis, Alzheimer's and inflammatory diseases. The aim of this review is to describe recent developments in the study of the antioxidant activity of thiazole and thiazolidinone derivatives, which are the core structure in a variety of pharmaceuticals with a broad spectrum of biological activity and their role in preventing the formation of ROS.
抗氧化剂因其参与重要的生物和工业过程而备受关注。根据哈利威尔的说法,抗氧化剂是在低浓度下能显著延迟或阻止氧化的物质。从化学角度来看,氧化是一个发生电子损失的过程。氧化剂在导致氧化应激的多种疾病的发病机制中起着重要作用。氧化应激可定义为细胞活性氧生成与抗氧化防御机制之间的失衡。活性氧(如超氧阴离子自由基、过氧亚硝基、羟基自由基和过氧化氢)是生物系统中代谢反应不断产生的结果。由活性氧引起的氧化损伤是许多退行性疾病的病因,如癌症、动脉粥样硬化、糖尿病、肝硬化、阿尔茨海默病和炎症性疾病。本综述的目的是描述噻唑和噻唑烷酮衍生物抗氧化活性研究的最新进展,它们是具有广泛生物活性的多种药物的核心结构,以及它们在预防活性氧形成中的作用。